CVC Capital Partners Submits Non-Binding Offer for Recordati
CVC Capital Partners has proposed a non-binding takeover of Recordati, valuing the Milan-listed pharmaceutical company at €10.9bn, as confirmed by Recordati. The offer includes a preliminary price of €52 per share and aims to take the company private, according to Private Equity Wire citing a Reuters report.
Details of the Proposal
The takeover proposal from CVC specifies that the deal is subject to several conditions, including the completion of due diligence, securing necessary financing, and identifying potential co-investors. Recordati’s share price has risen following confirmation of the approach, which built on earlier media reports about the potential deal. CVC already holds a 46.8% stake in Recordati, as per recent filings, and has formally notified the company’s board of its interest in a full acquisition.
Background and Market Context
Recordati, a Milan-listed group, has received this proposal amid broader interest in private equity takeovers of publicly traded firms, though such deals often face uncertainties. As widely known in the industry, private equity firms like CVC frequently pursue acquisitions to consolidate control, but this specific offer remains in early stages. According to Private Equity Wire, no agreement has been reached, and there is no certainty that the transaction will proceed.
Potential Implications
The proposal highlights CVC’s existing position in Recordati, with the firm seeking to expand its stake through this offer. While the deal’s outcome is uncertain due to the outlined conditions, it reflects ongoing activity in private equity transactions involving European companies, according to the report from Private Equity Wire.
